An Unusual Case of Henoch-Schönlein Purpura in an Elderly Male

Total Page:16

File Type:pdf, Size:1020Kb

An Unusual Case of Henoch-Schönlein Purpura in an Elderly Male An Unusual Case of Henoch-Schönlein Purpura in an Elderly Male Jeffrey Kushner, DO,* David Posnick, DO,** Joan M. Mones, DO,*** Adriana Ros, DO, FAOCD*** *PGY-1 Traditional Rotating Intern, Largo Medical Center, Largo, FL **PGY-3 Dermatology Resident, Palisades Medical Center, North Bergen, NJ ***Program Director, Dermatopathology Fellowship, New York College of Osteopathic Medicine/Ackerman Academy of Dermatopathology, New York, NY ****Program Director, Dermatology Residency, Palisades Medical Center, North Bergen, NJ Abstract Henoch-Schönlein purpura (HSP) is a subset of cutaneous small vessel vasculitis (CSVV) characterized by IgA deposition in the walls of small blood vessels leading to non-thrombocytopenic palpable purpura, typically of the lower extremities. Other immune factors such as IgM, IgG, complement, and fibrinogen may be found in vessels. The disease is characterized by a tetrad of manifestations including palpable purpura, arthralgia/arthritis, abdominal pain, and renal disease.1 Morbidity in the HSP patient population is correlated with chronic renal failure secondary to glomerulonephritis. HSP is rarely seen in the adult and geriatric population; approximately 90% of patients are children. We present a case of HSP in a nonverbal, nonambulatory 62-year-old Caucasian male. Henoch-SchönleinIntroduction purpura (HSP) is a cutaneous ACase 62-year-old, Report minimally verbal, non-ambulatory small vessel vasculitis with deposition of IgA and Caucasian male presented to the dermatology other immune factors within the vessel walls. outpatient clinic complaining of a new-onset The disease was originally identified in 1801 by rash on his lower extremities for one week. Johann Schönlein and his student, Eduard Henoch, The patient denied any symptoms of itching who described the clinical signs and symptoms.1 or pain. Clotrimazole/betamethasone topical It is highlighted by a tetrad of symptoms and cream prescribed by his internist showed no complications—palpable purpura, arthralgia/ improvement. The patient reported no known arthritis, abdominal pain, and renal disease. allergies and no significant family history of Although HSP is significantly more common in vasculitis or autoimmune disease. The patient’s the pediatric population, failure to diagnosis and extensive past medical history included: treat adults can have serious ramifications. We congestive heart failure, cerebral vascular report a case of HSP in a 62-year-old patient with accident, dementia, epilepsy, and dysphagia. an extensive past medical history who initially Medication list included clonazepam, warfarin, presented to the clinic with a lower extremity phenytoin, simvastatin, digoxin, furosemide, and rash. diltiazem. The patient did admit to a history of tobacco use. Figure 1. Multiple discrete, non-blanchable, purpuric papules with hemorrhagic crust on the anterior lower legs symmetrically. Page 26 AN UNUSUAL CASE OF HENOCH-SCHÖNLEIN PURPURA IN AN ELDERLY MALE Physical exam revealed multiple discrete, non- While HSP is associated with deposition of IgA in will develop chronic cases.1 blanchable, purpuric papules with hemorrhagic small blood vessels, there has also been literature Commonly reported extracutaneous crust on the anterior lower legs symmetrically reporting alterations in glycosylation of IgA and manifestations include arthritis, abdominal pain, (Figure 1). Provisional diagnoses included: elevated levels of IgA anticardiolipin antibodies.1 and renal disease. Of the reported symptoms, leukocytoclastic vasculitis secondary to drug, In adults, vascular IgA deposits are highly joint pain was the most common extracutaneous connective-tissue disease or HSP, folliculitis, specific for HSP, although not all patients may manifestation, occurring in up to 84 percent neurotic excoriations, scabies, insect bites, have a positive DIF.11 Additionally, complement of patients.1 The pain is usually transient and lymphomatoid papulosis, and pityriasis activation, glomerular crescent formation and oligoarticular and often afflicts the lower lichenoides et varioliformis acuta. vascular damage have been identified as important extremities, resulting in pain with ambulation. Two 3 mm punch biopsies were performed and mechanisms underlying renal involvement in Gastrointestinal symptoms are varied, ranging sent for routine hematoxylin and eosin (H&E) HSP. Multiple triggers for the condition have from mild nausea, vomiting and abdominal pain staining and direct immunofluorescence (DIF). been suggested, although the actual cause still to more emergent cases of intussusception, bowel One biopsy was obtained from the left superior remains unknown. In children, symptoms may be ischemia and perforation. The abdominal pain lateral tibia and another from the left inferior preceded by an upper respiratory infection, more has been attributed to submucosal hemorrhage medial tibia. A complete metabolic panel, specifically attributed to group A beta-hemolytic and edema. In cases with gastrointestinal 3 complete blood count with differential, urinalysis, streptococcus. Multiple disease states and drugs involvement, subclinical laboratory findings that and hepatitis panel were ordered. Labs on the have been implicated in the development of HSP may indicate more advanced disease include a a patient were unremarkable except for anemia including pregnancy, 1-antitrypisin deficiency, positive fecal occult blood test, hypoalbuminemia alcohol, vaccinations, chlorpromazine, losartan, (hemoglobin 11.1). Renal function was stable and a positive a1-antitripysin. (BUN: 11 creatinine: 0.6). H&E biopsy showed aspirin, and antimicrobials such as penicillin, 4-6 Adult manifestations of HSP do not necessarily evidence of early leukocytoclastic vasculitis ampicillin, clarithromycin, and erythromycin. present like those seen in the pediatric population. (Figure 2). DIF studies were compatible with HSP is characterized by both cutaneous and When compared to children, adults have a lower extracutaneous manifestations. Children almost incidence of prior upper respiratory infection universally present with erythematous, urticarial upon development of HSP. Abdominal pain and papules that rapidly develop into petechiae and fever are less prevalent during the course of the palpable purpura. Vesicles, bullae and necrotic disease in adults, while joint complaints and renal ulcers may also be present. The most common disease are increased.7 A higher frequency of locations for these findings are on pressure- nephrotic syndrome, hypertension and elevated dependent areas such as the buttocks and lower serum creatinine may be seen in the adult extremities, although the elbow and knees may population, which can be especially concerning also be involved.7 Individual lesions usually fade in the presence of comorbidities.8,9 Furthermore, within a week, resulting in hyperpigmentation, literature suggests that renal manifestations although recurrent lesions are possible. become even more prominent in elderly patients Cumulative skin manifestations usually last for compared to adults less than 60 years old.4 six to 16 weeks, although 5% to 10% of patients Figure 2. The changes of early leukocytoclastic A clinical diagnosis of HSP is usually made in vasculitis, including increased numbers children with the prevalence of cutaneous and of neutrophils, incipient nuclear dust of extracutanous manifestations, which are often neutrophils, and extravasation of erythrocytes present. However, the varied presentation in (H&E stain). adult patients may prove more challenging diagnostically. Purpura can be seen with infection, HSP/IgA vasculitis (Figure 3). There was also hypersensitivity vasculitis, rheumatoid arthritis, granular perivascular deposition of C3 and and other small vessel vasculitides. These smooth perivascular deposition of fibrinogen can include granulomatosis with polyangiitis but no perivascular deposition of IgM on DIF. (Wegener’s), microscopic polyangiitis, and Treatment plan included clobetasol 0.05% eosinophilic granulomatosis with polyangiitis 1 ointment every 12 hours to the lower extremities (Churg-Strauss syndrome). Rheumatoid arthritis for two weeks as well as nephrology consultation and systemic lupus erythematosus can mimic (pending). the joint complaints, while IgA nephropathy or Berger’s disease could present similar renal Discussion findings.8 HSP has an annual incidence of about 20 per A definitive diagnosis is usually based upon 100,000 children less than 17 years of age with both clinical manifestations and biopsy. A a peak incidence of 70 per 100,000 in children biopsy is more valuable in the adult population 2 between the ages of four and six years old. because HSP is less common and extracutaneous There is a slight male predominance. The disease symptoms are not always apparent. When occurs less frequently in African Americans, and assessing skin histopathology, proper sampling is more prevalent in the fall and winter months. techniques are paramount to yielding accurate The incidence of HSP in the adult population is Figure 3. Granular perivascular deposition of diagnostic results. A punch biopsy from the edge approximately 1.3 per 100,000 patients, and data IgA present in superficial dermal blood vessels of a fresh lesion, ideally less than 24 hours old, on the elderly population is even more sparse.3,4 (direct immunofluorescence). is the most effective and accurate technique.5 On KUSHNER, POSNICK, MONES, ROS Page 27 H&E staining, tissue will show a leukocytoclastic correlated with
Recommended publications
  • Expanding the Role of Dermatology at the World Health Organization and Beyond
    EDITORIAL A Seat at the Big Table: Expanding the Role of Dermatology at the World Health Organization and Beyond y patient can’t breathe. From across Kaposi’s sarcoma, seborrheic dermatitis, her- the busy, open ward, you can see the pes zoster, scabies, papular pruritic eruption, Mplaques of Kaposi’s sarcoma riddling eosinophilic folliculitis, tinea, molluscum, drug her skin. The impressive woody edema has reactions, and oral candidiasis (World Health enlarged her legs to the size of small tree trunks. Organization, in press). These conditions have We don’t have access to confirmatory pulmo- a high prevalence in developing countries, but nary testing in Kenya, but she probably wouldn’t many lack internationally agreed-on standards survive a bronchoscopy anyway. of care. This deficit led to inconsistent and some- When she dies six hours later, we can be pret- times dangerous treatment approaches or lack of ty sure that it is her pulmonary Kaposi’s sarcoma, essential drugs. Critically, dermatologists were along with her underlying HIV, that killed her. involved at all levels of the guideline-develop- Her family tells us that she had dark spots on ment process, including Cochrane reviews of the her skin and swelling in her legs for more than literature, guideline development and review, a year before she presented to the hospital. Like and additional funding for the project from many of our patients in East Africa, she sought the International Foundation for Dermatology help from a traditional healer for many months (http://www.ifd.org). before turning to the biomedical health system, Although diseases such as Kaposi’s sarcoma only hours before her death.
    [Show full text]
  • Apixaban-Induced Cutaneous Hypersensitivity: a Case Series with Evidence of Cross-Reactivity
    Volume 26 Number 10| October 2020| Dermatology Online Journal || Letter 26(10):20 Apixaban-induced cutaneous hypersensitivity: a case series with evidence of cross-reactivity Nasro A Isaq1 BS, Whitney M Vinson2 MD, Sahand Rahnama-Moghadam2 MD MS Affiliations: 1Indiana University School of Medicine, Indianapolis, Indiana, USA, 2Department of Dermatology, Indiana University School of Medicine, Indianapolis, Indiana, USA Corresponding Author: Sahand Rahnama-Moghadan MD MS, Department of Dermatology, Indiana University School of Medicine, 545 Barnhill Drive, Emerson Hall 139, Indianapolis, IN 46202, Tel: 317-944-7744, Email: [email protected] Keywords: novel oral anticoagulants (NOACs), apixaban, 2 weeks she developed low-grade fevers, chills, rivaroxaban, drug induced rash, apixaban hypersensitivity nausea, shortness of breath, headaches, and cough. reaction, rivaroxaban cross reactivity, novel oral She was admitted to the hospital where computed anticoagulant induced hypersensitivity reaction, apixaban tomography of the chest demonstrated ground glass induced rash opacities located peripherally within her lungs. Laboratory results showed a decrease in hemoglobin, elevated dsDNA, positive rheumatoid To the Editor: factor, and elevated beta-2 glycoprotein concerning Atrial fibrillation is the most common cardiac arrhythmia affecting more than 2.7 million patients for drug-induced lupus. Her apixaban was held owing to concern for hemorrhage. A in the US [1]. As the population ages, it is predicted bronchoalveolar lavage was performed revealing to affect more than 6-12 million people by 2050 [1]. eosinophilic predominance, suggestive of Patients with atrial fibrillation are at increased risk for eosinophilic pneumonia secondary to a connective thromboembolic events and require anticoagulation therapy to prevent thrombus formation and stroke. tissue disease versus drug reaction.
    [Show full text]
  • Cutaneous Manifestations of HIV Infection Carrie L
    Chapter Title Cutaneous Manifestations of HIV Infection Carrie L. Kovarik, MD Addy Kekitiinwa, MB, ChB Heidi Schwarzwald, MD, MPH Objectives Table 1. Cutaneous manifestations of HIV 1. Review the most common cutaneous Cause Manifestations manifestations of human immunodeficiency Neoplasia Kaposi sarcoma virus (HIV) infection. Lymphoma 2. Describe the methods of diagnosis and treatment Squamous cell carcinoma for each cutaneous disease. Infectious Herpes zoster Herpes simplex virus infections Superficial fungal infections Key Points Angular cheilitis 1. Cutaneous lesions are often the first Chancroid manifestation of HIV noted by patients and Cryptococcus Histoplasmosis health professionals. Human papillomavirus (verruca vulgaris, 2. Cutaneous lesions occur frequently in both adults verruca plana, condyloma) and children infected with HIV. Impetigo 3. Diagnosis of several mucocutaneous diseases Lymphogranuloma venereum in the setting of HIV will allow appropriate Molluscum contagiosum treatment and prevention of complications. Syphilis Furunculosis 4. Prompt diagnosis and treatment of cutaneous Folliculitis manifestations can prevent complications and Pyomyositis improve quality of life for HIV-infected persons. Other Pruritic papular eruption Seborrheic dermatitis Overview Drug eruption Vasculitis Many people with human immunodeficiency virus Psoriasis (HIV) infection develop cutaneous lesions. The risk of Hyperpigmentation developing cutaneous manifestations increases with Photodermatitis disease progression. As immunosuppression increases, Atopic Dermatitis patients may develop multiple skin diseases at once, Hair changes atypical-appearing skin lesions, or diseases that are refractory to standard treatment. Skin conditions that have been associated with HIV infection are listed in Clinical staging is useful in the initial assessment of a Table 1. patient, at the time the patient enters into long-term HIV care, and for monitoring a patient’s disease progression.
    [Show full text]
  • WHO GUIDELINES for the Treatment of Treponema Pallidum (Syphilis)
    WHO GUIDELINES FOR THE Treatment of Treponema pallidum (syphilis) WHO GUIDELINES FOR THE Treatment of Treponema pallidum (syphilis) WHO Library Cataloguing-in-Publication Data WHO guidelines for the treatment of Treponema pallidum (syphilis). Contents: Web annex D: Evidence profiles and evidence-to-decision frameworks - Web annex E: Systematic reviews for syphilis guidelines - Web annex F: Summary of conflicts of interest 1.Syphilis – drug therapy. 2.Treponema pallidum. 3.Sexually Transmitted Diseases. 4.Guideline. I.World Health Organization. ISBN 978 92 4 154980 6 (NLM classification: WC 170) © World Health Organization 2016 All rights reserved. Publications of the World Health Organization are available on the WHO website (http://www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; email: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for non-commercial distribution– should be addressed to WHO Press through the WHO website (http://www.who.int/about/licensing/ copyright_form/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned.
    [Show full text]
  • ANCA--Associated Small-Vessel Vasculitis
    ANCA–Associated Small-Vessel Vasculitis ISHAK A. MANSI, M.D., PH.D., ADRIANA OPRAN, M.D., and FRED ROSNER, M.D. Mount Sinai Services at Queens Hospital Center, Jamaica, New York and the Mount Sinai School of Medicine, New York, New York Antineutrophil cytoplasmic antibodies (ANCA)–associated vasculitis is the most common primary sys- temic small-vessel vasculitis to occur in adults. Although the etiology is not always known, the inci- dence of vasculitis is increasing, and the diagnosis and management of patients may be challenging because of its relative infrequency, changing nomenclature, and variability of clinical expression. Advances in clinical management have been achieved during the past few years, and many ongoing studies are pending. Vasculitis may affect the large, medium, or small blood vessels. Small-vessel vas- culitis may be further classified as ANCA-associated or non-ANCA–associated vasculitis. ANCA–asso- ciated small-vessel vasculitis includes microscopic polyangiitis, Wegener’s granulomatosis, Churg- Strauss syndrome, and drug-induced vasculitis. Better definition criteria and advancement in the technologies make these diagnoses increasingly common. Features that may aid in defining the spe- cific type of vasculitic disorder include the type of organ involvement, presence and type of ANCA (myeloperoxidase–ANCA or proteinase 3–ANCA), presence of serum cryoglobulins, and the presence of evidence for granulomatous inflammation. Family physicians should be familiar with this group of vasculitic disorders to reach a prompt diagnosis and initiate treatment to prevent end-organ dam- age. Treatment usually includes corticosteroid and immunosuppressive therapy. (Am Fam Physician 2002;65:1615-20. Copyright© 2002 American Academy of Family Physicians.) asculitis is a process caused These antibodies can be detected with indi- by inflammation of blood rect immunofluorescence microscopy.
    [Show full text]
  • Immune-Pathophysiology and -Therapy of Childhood Purpura
    Egypt J Pediatr Allergy Immunol 2009;7(1):3-13. Review article Immune-pathophysiology and -therapy of childhood purpura Safinaz A Elhabashy Professor of Pediatrics, Ain Shams University, Cairo Childhood purpura - Overview vasculitic disorders present with palpable Purpura (from the Latin, purpura, meaning purpura2. Purpura may be secondary to "purple") is the appearance of red or purple thrombocytopenia, platelet dysfunction, discolorations on the skin that do not blanch on coagulation factor deficiency or vascular defect as applying pressure. They are caused by bleeding shown in table 1. underneath the skin. Purpura measure 0.3-1cm, A thorough history (Table 2) and a careful while petechiae measure less than 3mm and physical examination (Table 3) are critical first ecchymoses greater than 1cm1. The integrity of steps in the evaluation of children with purpura3. the vascular system depends on three interacting When the history and physical examination elements: platelets, plasma coagulation factors suggest the presence of a bleeding disorder, and blood vessels. All three elements are required laboratory screening studies may include a for proper hemostasis, but the pattern of bleeding complete blood count, peripheral blood smear, depends to some extent on the specific defect. In prothrombin time (PT) and activated partial general, platelet disorders manifest petechiae, thromboplastin time (aPTT). With few exceptions, mucosal bleeding (wet purpura) or, rarely, central these studies should identify most hemostatic nervous system bleeding;
    [Show full text]
  • DIFFERENTIAL DIAGNOSIS of Hypersensitivity Vasculitis
    HIGHLIGHTS FROM MEDICAL GRAND ROUNDS renal disease also is rare. However, certain types of kidney posure to an exogenous antigen such as a drug, serum, disease are associated with a higher incidence of hyper- toxin, or to an infection. Typically, the onset of vasculitis uricemia and gout, including chronic lead nephropathy, occurs 7 to 10 days after exposure to the antigen. The polycystic disease, amyloidosis, analgesic nephropathy, characteristic rash presents as palpable purpura, although and medullary cystic disease. Hypertension and its ulcers, nodules, bullae, or urticaria also may develop in therapy are associated with an increased incidence of some patients. hyperuricemia and gout. On biopsy, the lesions display polymorphonuclear The management of concurrent marked hyper- leukocytes and associated leukocytoclasis, but the in- uricemia and chronic renal disease is directed to preser- filtrates may be predominantly mononuclear. Im- vation of renal function, blood pressure control, and munofluorescent studies often show deposition of com- reduction of the serum uric acid. Uric acid homeostasis plement and immunoglobulins in vessel walls, and other can be achieved by maintaining urine flow (>2 L/d), techniques may show soluble immune complexes and restricting dietary purines and excessive alcohol, and, if evidence of complement activation; however, these needed, allopurinol in the lowest dose that can main- laboratory findings are neither universal nor necessary for tain a near-normal serum uric acid. Therapy should the diagnosis. start with 50 mg/d and increase in 50-mg increments The clinical course is usually self-limited. Varying until the level is under control. Generally, the dosage is degrees of fever, malaise, and weight loss may occur and 100 mg/d for every 30 cc/min of GFR.
    [Show full text]
  • Pedianews Volume VI, Issue II the Official Newsletter of the Student Society of Pediatric Advocates (Rxpups) May 2018
    1 PediaNews Volume VI, Issue II The Official Newsletter of the Student Society of Pediatric Advocates (RxPups) May 2018 Inside this issue LICEnse to Kill LICEnse to Kill ................... 1-2 Written by: Kirty Patel, Pharm.D. Candidate 2020 Pediatric Idiopathic Thrombocytopenia Purpura ................................. 3-5 It is a dreadful feeling of anxiety when any parent, teacher, or Obesity in Children .......... 6-8 other caregiver discovers lice in a child’s hair. They begin to look back on the past few days and realize that the child has been scratching their Editors head frequently, which is a common sign of head lice. The itching is caused by an allergic reaction to louse saliva. The caregiver may wonder Linda Logan, Pharm.D., BCPS, BCACP why they didn’t previously notice the symptoms but know they can Faculty Advisor contact their local pharmacist with questions, concerns, and guidance Alicia Sanchez, Pharm.D., for the treatment process. PGY2 Pediatric Pharmacy Upon obtaining the phone call, the pharmacist wants to confirm Resident that the child does in fact have lice. The pharmacist explains to the Namita Patel, PharmD caregiver that although lice are small, they can be detected by the Candidate Class of 2019 University of Georgia naked eye. The best way to detect a child’s current state of infestation College of Pharmacy is to examine their scalp for nits (lice eggs) using a magnifying lens and a toothpick comb. Empty nits are lighter in color and further from the scalp, but do not necessarily indicate an active infiltration of lice.1 It is also important to be aware that nits can be misidentified as dandruff, hair spray residue, or even dirt particles that have lodged into the patient’s scalp.
    [Show full text]
  • Scabies, Incomplete Lupus Erythematosus and Henoch-Schonlein Purpura: a Case Report
    Scabies, Incomplete Lupus Erythematosus and Henoch-Schonlein Purpura: A Case Report Yang Fang Wu First Aliated Hospital of Anhui Medical University Jing Jing Wang Jinling Hospital Hui Hui Liu First Aliated Hospital of Anhui Medical University Wei Xia Chen First Aliated Hospital of Anhui Medical University Peng Hu ( [email protected] ) First Aliated Hospital of Anhui Medical University https://orcid.org/0000-0002-2144-9806 Case report Keywords: Antinuclear antibody, Henoch-Schonlein purpura, immunoglobulin A, proteinuria, scabies Posted Date: September 18th, 2020 DOI: https://doi.org/10.21203/rs.3.rs-63971/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/8 Abstract BackgroundHenoch-Schonlein purpura (HSP) is a common autoimmune vasculitis in childhood. Although the detailed etiology of HSP remains unknown, several triggers, especially for infectious agents, have been proved to be associated with HSP onset. Case presentation: In the present report, we describe an unusual patient who suffered from HSP and incomplete lupus erythematosus (ILE) on day 8 after scabies, mainly based on nonthrombocytopenic purpura, abdominal pain, medium proteinuria, positive antinuclear antibody (ANA) and skin scrapings. A course of pulse methylprednisolone (10mg/kg/day) was administered for 6 days, followed by oral prednisone (1mg/kg/day). On day 18, the purpuric rashes almost disappeared, whereas medium proteinuria still existed. In this circumstance, a renal biopsy was performed with the informed consent of the parents. According to the criteria proposed by the International Study of Kidney Disease in Children, this patient was classied as class IIIb. The immunouorescence microscopy revealed granular deposits of IgA, IgM and C3 in the glomerular mesangium.
    [Show full text]
  • Teledermatology and Common Dermatology Issues in the Hospitalized Patient
    Teledermatology and Common Dermatology Issues in the Hospitalized Patient Patricia Meyer, DNP, CRNP, FNP‐BC, AGACNP‐BC, NE‐BC The Rise of Teledermatology Improve Shortage of Ability for dermatology dermatology dermatologist to access providers see more patients • Obtaining a CC, HPI, ROS, Allergies, Med list , PMH, Social and Family Hx • A problem‐focused exam • Digital imaging • Uploading of‐ CC, HPI, ROS, Allergies, Med list , PMH, Social and Family Hx, Physical exam, and digital images via secure computer site • Onsite person to obtain BX if needed Teledermatology What is Involved After Info is Uploaded • Dermatologist will form differential diagnosis • Suggest a work up • Formulate and assessment and plan Teledermatology What is Involved • Medication list, prescription and over‐the‐counter drugs • History of past reactions to drugs or foods, topicals, soaps, detergents • Any recent illness ? Exposure to others with similar s/s • Any concurrent infections, metabolic disorders, or immunocompromise, or hx of History Needed autoimmune issues, hx of CA? • Any note in correlation with medication administration and rash onset? • How was medication administered? • Improvement if medication stopped and symptom reoccurrence if medication restarted? Worrisome • Mucous membrane erosions • Blisters Physical Exam • Nikolsky sign Features and • Confluent erythema symptoms • Angioedema and tongue swelling • Palpable purpura • Skin necrosis • Lymphadenopathy • High fever, dyspnea, or hypotension HJ is a 82 year old male, who was admitted from SNF, due to abd pain. HJ is being treated for diverticulitis with Cipro and Flagyl. Teledermatolgy is consulted due to a “rash.” Per the patient’s RN , “it is unclear if this is a new drug rash”. Upon further review with patient he states that he has had this rash for some time “it is very itchy and often keeps me up at night .” He denies any worsening or improving factors.
    [Show full text]
  • PATIENT INFORMATION LEAFLET Genital Warts
    PATIENT INFORMATION LEAFLET E A D V Genital warts (Condylomata acuminata) task force “skin disease in pregnancy” The aim of this leaflet This leaflet has been written to help you understand more about genital warts. It will tell you what it is, what causes it, what can be done about it, and where you can find out more information about it. What are genital warts? Genital or more accurately anogenital warts are skin lesions of the genital, perineal and anal areas; the medical term is condylomata acuminata. What causes genital warts? Genital warts are an infectious disease caused by sexually transmitted viruses, the Human Papilloma Virus (HPV), types 6 and 11. The incubation period (time between infectious contact and showing clinical signs) can be as long as eight months. Most infections by HPV cause no symptoms and clear within 2 years. This means that you might not realize that you carry the virus, (and there is a chance that you may infect another person without knowing it). The virus can persist for months or years in the skin, with or without symptoms. If the warts reappear after clearing it is usually due to the original not a new infection. Infection can occur in up to 30% of women between 20 and 30 years of age; elderly women are less frequently affected. Are genital warts hereditary? No. What are the signs and symptoms of genital warts? The presence of external genital warts (at the outside of the ano-genital skin) is nearly always detected by the woman herself. You do not usually feel them but there may be some degree of itching.
    [Show full text]
  • Epidemiology, Diagnosis, and Treatment of Scabies in a Dermatology Office
    J Am Board Fam Med: first published as 10.3122/jabfm.2017.01.160190 on 6 January 2017. Downloaded from ORIGINAL RESEARCH Epidemiology, Diagnosis, and Treatment of Scabies in a Dermatology Office Kathryn L. Anderson, MD, and Lindsay C. Strowd, MD Background: Scabies is a neglected skin disease, and little is known about current incidence and treat- ment patterns in the United States. The purpose of this study was to examine demographic data, treat- ment types, success of treatment, and misdiagnosis rate of scabies in an outpatient dermatology clinic. Methods: A retrospective chart review of patients diagnosed with scabies within the past 5 years was performed. Results: A total of 459 charts were identified, with 428 meeting inclusion criteria. Demographic data, diagnostic method, treatment choice, misdiagnosis rate, treatment failure, and itching after scabies are also reported. Children were the largest age group diagnosed with scabies, at 38%. Males (54%) were diagnosed with scabies more than females. The majority of diagnoses were made by visualizing ova, feces, or mites on light microscopy (58%). At the time of diagnosis, 45% of patients had been misdiag- nosed by another provider. Topical permethrin was the most common treatment used (69%), followed by a combination of topical permethrin and oral ivermectin (23%), oral ivermectin (7%), and other treatments (1%). Conclusion: Our findings suggest that more accurate and faster diagnostic methods are needed to limit unnecessary treatment and expedite appropriate therapy for scabies. (J Am
    [Show full text]